01
What it does
peer review; utilization management; prior authorization; specialty drug review; peer-to-peer consultation; appeals management
02
Evaluation criteria
IME Hub rubric4 of 8 published
✓
Processing model
AI + Human QA
✓
Human QA
Included
○
Typical turnaround
Not published
○
Pricing model
Not published
○
Indicative cost
Not published
○
Export formats
Not published
✓
Best for
Utilization Management & Appeals for Health Plans/PBMs
✓
Customer satisfaction
No public reviews found
03
Profile notes
Who it serves
group health; PBM/pharmacy; government/ACO; employer/union plans
Claims & platform notes
900+ clients; 2.4 million reviews annually (self-reported)
Review summary
Verdict: conditional. The provider-directory corpus shows multiple MRIoA brand rows (merged in this hub); service scope is IME + peer review. Pricing and current panel data not verified in v1.
Competitive coverage
Key facts
| Segment | IME / Peer Review / UR / Bill Review |
| Website | |
| Founded | Not published exact year; site states "40+ years" of experience (implies founding circa mid-1980s) |
| HQ | Not published (commonly cited as Murray/Salt Lake City, UT area in third-party listings — unverified this pass) |
| Ownership | Not published (recent CEO appointment: Megan Callahan); no PE/public ownership disclosed on site |
| Turnaround | 98% turnaround-time target achievement rate (self-reported) |
| Certifications | Not published explicitly on fetched content (industry-known to hold URAC/NCQA-type accreditations; not directly confirmed this pass) |
| Not published | Headcount · Pricing |
